DGAP-Adhoc: MeVis Medical Solutions AG: Agreement on the

MeVis Medical Solutions AG / Key word(s): Miscellaneous 29.04.2015 11:34 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Bremen, April 29, 2015 - The management of VMS Deutschland Holdings GmbH, Darmstadt, and the Executive Board of MeVis Medical Solutions AG [ISIN: DE000A0LBFE4] have agreed today to prepare and to close a domination agreement between VMS Deutschland Holdings GmbH as controlling company and MeVis Medical Solutions AG as controlled company. The cash compensation and guaranteed dividend for minority shareholders of MeVis Medical Solutions AG will be determined in accordance with the statutory requirements and on the basis of a pending evaluation of the company. In order to become effective, the intended domination agreement requires the approval of the general shareholders' meeting of MeVis Medical Solutions AG, which will be scheduled in the second half of the year. VMS Deutschland Holdings GmbH, an affiliate of Varian Medical Systems, Inc., Palo Alto, California, USA, published a voluntary public takeover offer on January 27, 2015 to all shareholders of MeVis Medical Solutions AG to acquire their registered non-par value shares against payment of 17.50 Euros per share. The offer was accepted for 1,337,995 shares (representing 73.52 % of the total share capital). The settlement of the offer was completed on April 21, 2015, so that VMS Deutschland Holdings GmbH acquired on this date the majority of shares in MeVis Medical Solutions AG. 29.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Phone: +49 421 224 95 0 Fax: +49 421 224 95 999 E-mail: ir@mevis.de Internet: http://www.mevis.de ISIN: DE000A0LBFE4 WKN: A0LBFE Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------